{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:03:32Z","timestamp":1791493412432,"version":"4.3.4"},"reference-count":344,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"abstract":"<jats:p>Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing\u2019s disease and acromegaly, retrospectively. For patients with acromegaly, the role of IGF-I is less clear-cut. Confounding pituitary hormone deficiencies such as gonadotropins and particularly ACTH deficiency (with higher doses of hydrocortisone replacement) may have a detrimental effect on outcome in patients with pituitary disease. Pituitary radiotherapy is a further factor that has been associated with increased mortality (particularly cerebrovascular). Although standardized mortality ratios in pituitary disease are falling due to improved treatment, mortality for many conditions are still elevated above that of the general population, and therefore further measures are needed. Craniopharyngioma patients have a particularly increased risk of mortality as a result of the tumor itself and treatment to control tumor growth; this is a key area for future research in order to optimize the outcome for these patients.<\/jats:p>","DOI":"10.1210\/er.2009-0033","type":"journal-article","created":{"date-parts":[[2010,6,4]],"date-time":"2010-06-04T17:23:52Z","timestamp":1275672232000},"page":"301-342","source":"Crossref","is-referenced-by-count":335,"title":["Mortality in Patients with Pituitary Disease"],"prefix":"10.1210","volume":"31","author":[{"given":"Mark","family":"Sherlock","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (M.S., J.A., J.W.T., A.A.T., A.A.-A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ayuk","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (M.S., J.A., J.W.T., A.A.T., A.A.-A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy W.","family":"Tomlinson","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (M.S., J.A., J.W.T., A.A.T., A.A.-A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Toogood","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (M.S., J.A., J.W.T., A.A.T., A.A.-A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Aragon-Alonso","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (M.S., J.A., J.W.T., A.A.T., A.A.-A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Sheppard","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (M.S., J.A., J.W.T., A.A.T., A.A.-A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Bates","sequence":"first","affiliation":[{"name":"Birmingham Heartlands and Solihull National Health Service Trust (A.S.B.), Birmingham B9 5SS, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Stewart","sequence":"first","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism (M.S., J.A., J.W.T., A.A.T., A.A.-A., M.C.S., P.M.S.), School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TH, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071611542863200_R1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ecl.2007.10.004","article-title":"Hypopituitarism: clinical features, diagnosis, and management.","volume":"37","author":"Toogood","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2020071611542863200_R2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain.","volume":"55","author":"Regal","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review.","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"2020071611542863200_R4","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R5","author":"Fernandez","year":"2009"},{"key":"2020071611542863200_R6","year":"2009"},{"key":"2020071611542863200_R7","first-page":"1420","article-title":"and 1991: incidence, survival, and mortality.","volume":"85","author":"Nilsson","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R8","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.298.12.1429","article-title":"Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review.","volume":"298","author":"Schneider","year":"2007","journal-title":"JAMA"},{"key":"2020071611542863200_R9","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1210\/jc.2005-1525","article-title":"Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults.","volume":"90","author":"Agha","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2265.1994.tb02583.x","article-title":"The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism.","volume":"41","author":"Toogood","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism.","volume":"336","author":"Rose\u0301n","year":"1990","journal-title":"Lancet"},{"key":"2020071611542863200_R12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"2020071611542863200_R13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/eje.0.1400383","article-title":"Pituitary tumours in the elderly: a 20 year experience.","volume":"140","author":"Turner","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R14","author":"Kirkwood","year":"2003"},{"key":"2020071611542863200_R15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11102-007-0018-x","article-title":"Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function.","volume":"10","author":"Nielsen","year":"2007","journal-title":"Pituitary"},{"key":"2020071611542863200_R16","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy.","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2265.1999.00650.x","article-title":"Life expectancy following surgery for pituitary tumours.","volume":"50","author":"Bates","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism.","volume":"46","author":"Bu\u0308low","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-07-0013","article-title":"Mortality and GH deficiency: a nationwide study.","volume":"157","author":"Stochholm","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R20","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy.","volume":"89","author":"Svensson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2265.2007.02947.x","article-title":"Excess mortality in women with pituitary disease: a meta-analysis.","volume":"67","author":"Nielsen","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R22","unstructured":"Gabriel SR, Carmona L, Roque M, Sanchez GL, Bonfill X 2005 Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev CD002229"},{"key":"2020071611542863200_R23","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1210\/jc.2005-1207","article-title":"Estrogen replacement in women of fertile years with hypopituitarism.","volume":"90","author":"Mah","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"2020071611542863200_R25","first-page":"1","article-title":"Growth hormone, insulin-like growth factor-I and the cortisol- cortisone shuttle.","volume":"56(Suppl 1)","author":"Stewart","year":"2001","journal-title":"Horm Res"},{"key":"2020071611542863200_R26","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM198511143132005","article-title":"The autopsy as a measure of accuracy of the death certificate.","volume":"313","author":"Kircher","year":"1985","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01600228","article-title":"The accuracy of death certificates. Implications for health statistics.","volume":"419","author":"Nielsen","year":"1991","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"2020071611542863200_R28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF00052751","article-title":"Accuracy of death certificates: a population-based, complete-coverage, one-year autopsy study in East Germany.","volume":"3","author":"Modelmog","year":"1992","journal-title":"Cancer Causes Control"},{"key":"2020071611542863200_R29","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0046-8177(98)90018-1","article-title":"The necessary role of the autopsy in cardiovascular epidemiology.","volume":"29","author":"Smith","year":"1998","journal-title":"Hum Pathol"},{"key":"2020071611542863200_R30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.smj.0000224337.77074.57","article-title":"Death certificates are not reliable: revivification of the autopsy.","volume":"99","author":"Ravakhah","year":"2006","journal-title":"South Med J"},{"key":"2020071611542863200_R31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/eje.0.1500149","article-title":"Direct causes of death in Japanese patients with hypopituitarism as analyzed from a nation-wide autopsy database.","volume":"150","author":"Kaji","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2265.1995.tb01860.x","article-title":"Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults.","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R33","first-page":"229","article-title":"CT-determined body composition changes with recombinant human growth hormone treatment to adults with growth hormone deficiency.","volume":"60","author":"Lo\u0308nn","year":"1993","journal-title":"Basic Life Sci"},{"key":"2020071611542863200_R34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2337\/diacare.9.2.153","article-title":"Role of obesity and fat distribution in non-insulin-dependent diabetes mellitus in Mexican Americans and non-Hispanic whites.","volume":"9","author":"Haffner","year":"1986","journal-title":"Diabetes Care"},{"key":"2020071611542863200_R35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/jcem-54-2-254","article-title":"Relation of body fat distribution to metabolic complications of obesity.","volume":"54","author":"Kissebah","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","article-title":"Growth hormone-deficient adults are insulin-resistant.","volume":"44","author":"Johansson","year":"1995","journal-title":"Metabolism"},{"key":"2020071611542863200_R37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2265.2001.01320.x","article-title":"Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.","volume":"55","author":"Abdu","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/eje.1.02179","article-title":"hypopituitary GH-deficient adults\u2014a KIMS database analysis.","volume":"155","author":"Abs","year":"2589","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R39","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/jcem.86.8.7774","article-title":"Hypopituitarsim is associated with triglyceride enrichment of very low-density lipoprotein.","volume":"86","author":"Kearney","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1365-2265.2002.01663.x","article-title":"Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors.","volume":"57","author":"Leonsson","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R41","first-page":"2448","article-title":"Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.","volume":"81","author":"O'Neal","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2265.1999.00682.x","article-title":"Cardiovascular disease and risk factors in adults with hypopituitarism.","volume":"50","author":"Beshyah","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R43","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.","volume":"42","author":"Cuneo","year":"1993","journal-title":"Metabolism"},{"key":"2020071611542863200_R44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0026-0495(94)90245-3","article-title":"Serum lipid levels in growth hormone-deficient men.","volume":"43","author":"Boer","year":"1994","journal-title":"Metabolism"},{"key":"2020071611542863200_R45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/acta.0.1290195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency.","volume":"129","author":"Rose\u0301n","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071611542863200_R46","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1530\/eje.0.1410481","article-title":"Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status. Collaborative ODA (Observational GH Deficiency in Adults) Group.","volume":"141","author":"Sanmarti\u0301","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.ijo.0800618","article-title":"The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.","volume":"22","author":"Vahl","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071611542863200_R48","first-page":"1671","article-title":"Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses.","volume":"77","author":"Amato","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R49","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0140-6736(92)92892-J","article-title":"Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults.","volume":"340","author":"Markussis","year":"1992","journal-title":"Lancet"},{"key":"2020071611542863200_R50","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM197806012982202","article-title":"A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes.","volume":"298","author":"Merimee","year":"1978","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R51","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2265.1995.tb02928.x","article-title":"Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism.","volume":"43","author":"Dunne","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.1998.00281.x","article-title":"Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency.","volume":"48","author":"Longobardi","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R53","first-page":"1658","article-title":"Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency.","volume":"77","author":"Merola","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2265.1994.tb01827.x","article-title":"Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults.","volume":"41","author":"Thuesen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199901073400103","article-title":"Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.","volume":"340","author":"O'Leary","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R56","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1210\/jcem.87.7.8655","article-title":"Peripheral vascular structure and function in men with contrasting GH levels.","volume":"87","author":"Irving","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R57","first-page":"453","article-title":"Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R58","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/jcem.86.3.7268","article-title":"Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.","volume":"86","author":"Lanes","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2265.2002.01559.x","article-title":"Growth hormone deficiency and vascular risk.","volume":"57","author":"McCallum","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R61","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1365-2265.2007.02986.x","article-title":"Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency","volume":"67","author":"Andreassen","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R62","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2265.2006.02518.x","article-title":"Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.","volume":"64","author":"Go\u0301mez","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1046\/j.1365-2265.2003.01832.x","article-title":"Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness.","volume":"59","author":"Leonsson","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R64","first-page":"58","article-title":"Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy.","volume":"84","author":"Serri","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R65","first-page":"370","article-title":"Plasminogen activator inhibitor-1: a common denominator in cardiovascular disease.","volume":"46","author":"Vaughan","year":"1998","journal-title":"J Investig Med"},{"key":"2020071611542863200_R66","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1210\/jc.2007-0609","article-title":"Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency.","volume":"92","author":"Devin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R67","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","article-title":"High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.","volume":"14","author":"Johansson","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"2020071611542863200_R68","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0038-1650594","article-title":"Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.","volume":"76","author":"Johansson","year":"1996","journal-title":"Thromb Haemost"},{"key":"2020071611542863200_R69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2265.2000.01002.x","article-title":"Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement.","volume":"52","author":"Kvasnicka","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R70","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2362.2005.01474.x","article-title":"Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency.","volume":"35","author":"Krzyzanowska","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"2020071611542863200_R71","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1210\/jcem.86.12.8087","article-title":"Inflammatory cardiovascular risk markers in women with hypopituitarism.","volume":"86","author":"Sesmilo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/317533","article-title":"High frequency of serious infections in patients with panhypopituitarism: a case- control study.","volume":"32","author":"Sharma","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020071611542863200_R73","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2249.2009.03881.x","article-title":"Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults.","volume":"156","author":"Mukherjee","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2020071611542863200_R74","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/eji.200526128","article-title":"Dehydroepiandrosterone replacement in patients with Addison\u2019s disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells.","volume":"35","author":"Coles","year":"2005","journal-title":"Eur J Immunol"},{"key":"2020071611542863200_R75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1474-9728.2004.00109.x","article-title":"Hormones and immune function: implications of aging.","volume":"3","author":"Arlt","year":"2004","journal-title":"Aging Cell"},{"key":"2020071611542863200_R76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1677\/joe.0.1760293","article-title":"The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity.","volume":"176","author":"Tanriverdi","year":"2003","journal-title":"J Endocrinol"},{"key":"2020071611542863200_R77","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison\u2019s disease: a population-based study.","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R78","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R79","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement and radiotherapy are independent predictors of mortality in patients with acromegaly.","volume":"94","author":"Sherlock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R80","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"2020071611542863200_R81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry.","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R82","first-page":"1505","article-title":"Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis.","volume":"76","author":"Kerrigan","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R83","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2265.1997.780907.x","article-title":"Glucocorticoid replacement therapy: are patients over treated and does it matter?","volume":"46","author":"Peacey","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R84","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1365-2265.2004.02035.x","article-title":"Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.","volume":"60","author":"Agha","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R85","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/joe.0.1690065","article-title":"Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.","volume":"169","author":"Charmandari","year":"2001","journal-title":"J Endocrinol"},{"key":"2020071611542863200_R87","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/j.1552-4604.1991.tb01906.x","article-title":"Pharmacokinetics and oral bioavailability of hydrocortisone.","volume":"31","author":"Derendorf","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"2020071611542863200_R88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2265.1997.2101025.x","article-title":"Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.","volume":"47","author":"DeVile","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R89","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2265.1997.1340955.x","article-title":"An assessment of optimal hydrocortisone replacement therapy.","volume":"46","author":"Howlett","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R90","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.2005.02320.x","article-title":"Why is the management of glucocorticoid deficiency still controversial: a review of the literature.","volume":"63","author":"Crown","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.2006.02544.x","article-title":"Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.","volume":"65","author":"Merza","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-07-0052","article-title":"Continuous subcutaneous hydrocortisone infusion in Addison\u2019s disease.","volume":"157","author":"L\u00f8va\u030as","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R93","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-08-0874","article-title":"Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy.","volume":"160","author":"Debono","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/EJE-09-0170","article-title":"Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.","volume":"161","author":"Johannsson","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R95","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2008-2380","article-title":"Modified-release hydrocortisone to provide circadian cortisol profiles.","volume":"94","author":"Debono","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R96","author":"Verma","year":"2009"},{"key":"2020071611542863200_R97","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2265.1996.d01-1552.x","article-title":"Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism.","volume":"45","author":"Al-Shoumer","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R98","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2265.1995.tb02602.x","article-title":"Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.","volume":"42","author":"al-Shoumer","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R99","first-page":"135","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.","volume":"18","author":"White","year":"1997","journal-title":"Endocr Rev"},{"key":"2020071611542863200_R100","doi-asserted-by":"crossref","unstructured":"White PC, Rogoff D, McMillan DR, Lavery GG 2007 Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism. Mol Cell Endocrinol 265\u2013266:89\u201392","DOI":"10.1016\/j.mce.2006.12.022"},{"key":"2020071611542863200_R101","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2- Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr Rev"},{"key":"2020071611542863200_R102","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","article-title":"The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.","volume":"84","author":"Bengtsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R103","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R104","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.1.01817","article-title":"One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.","volume":"152","author":"Boguszewski","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R105","first-page":"1874","article-title":"Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.","volume":"86","author":"Colao","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"key":"2020071611542863200_R107","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/eje.0.1360157","article-title":"Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults.","volume":"136","author":"Markussis","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R108","first-page":"1329","article-title":"Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.","volume":"84","author":"Borson-Chazot","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R109","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients.","volume":"84","author":"Gibney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2265.2000.01108.x","article-title":"Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.","volume":"53","author":"Florakis","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R111","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.ATV.13.2.296","article-title":"Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.","volume":"13","author":"Ede\u0301n","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"2020071611542863200_R112","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/000456329603300408","article-title":"Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency.","volume":"33","author":"O'Halloran","year":"1996","journal-title":"Ann Clin Biochem"},{"key":"2020071611542863200_R113","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1054\/ghir.2000.0172","article-title":"Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults.","volume":"10","author":"Wieringa","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"2020071611542863200_R114","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.2007.02763.x","article-title":"Modulation of glucocorticoid metabolism by the growth hormone-IGF-1 axis.","volume":"66","author":"Agha","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R115","first-page":"4172","article-title":"Modulation of 11\u03b2-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.","volume":"84","author":"Moore","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R116","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1210\/jc.2004-1114","article-title":"Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients.","volume":"89","author":"Giavoli","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R117","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","article-title":"Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease.","volume":"87","author":"Andersen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R118","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.","volume":"331","author":"Sawin","year":"1994","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R119","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study.","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"key":"2020071611542863200_R120","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/jc.2007-0179","article-title":"Review: the association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship?","volume":"92","author":"Vo\u0308lzke","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R121","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study.","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"2020071611542863200_R122","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"2020071611542863200_R123","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomised trials on the long-term effects of hormone replacement therapy.","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"2020071611542863200_R124","doi-asserted-by":"crossref","unstructured":"Farquhar C, Marjoribanks J, Lethaby A, Suckling JA, Lamberts Q 2009 Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev CD004143","DOI":"10.1002\/14651858.CD004143.pub3"},{"key":"2020071611542863200_R125","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(09)61526-9","article-title":"Oestrogen plus progestin and lung cancer in postmenopausal women (Women\u2019s Health Initiative trial): a post-hoc analysis of a randomised controlled trial.","volume":"374","author":"Chlebowski","year":"2009","journal-title":"Lancet"},{"key":"2020071611542863200_R126","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.amjmed.2009.05.021","article-title":"Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women.","volume":"122","author":"Salpeter","year":"2009","journal-title":"Am J Med"},{"key":"2020071611542863200_R127","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","article-title":"Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study.","volume":"116","author":"Khaw","year":"2007","journal-title":"Circulation"},{"key":"2020071611542863200_R128","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archinte.167.12.1252","article-title":"Sex steroids and all-cause and cause-specific mortality in men.","volume":"167","author":"Araujo","year":"2007","journal-title":"Arch Intern Med"},{"key":"2020071611542863200_R129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","article-title":"Androgens and cardiovascular disease.","volume":"24","author":"Liu","year":"2003","journal-title":"Endocr Rev"},{"key":"2020071611542863200_R130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/er.2001-0025","article-title":"Androgens and coronary artery disease.","volume":"24","author":"Wu","year":"2003","journal-title":"Endocr Rev"},{"key":"2020071611542863200_R131","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","article-title":"Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline.","volume":"91","author":"Bhasin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R132","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsbmb.2009.01.014","article-title":"Testosterone deficiency syndrome: treatment and cancer risk.","volume":"114","author":"Raynaud","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071611542863200_R133","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2265.2006.02545.x","article-title":"Hypopituitarism and mortality in pituitary adenoma.","volume":"65","author":"Lindholm","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R134","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1530\/eje.0.1500497","article-title":"Doubled mortality rate in irradiated patients reoperated for regrowth of a macroadenoma of the pituitary gland.","volume":"150","author":"Erfurth","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1009965803750","article-title":"Epidemiology of acromegaly.","volume":"2","author":"Holdaway","year":"1999","journal-title":"Pituitary"},{"key":"2020071611542863200_R136","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJM199004053221405","article-title":"Acromegaly.","volume":"322","author":"Melmed","year":"1990","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R137","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management.","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"key":"2020071611542863200_R138","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","article-title":"Epidemiology of acromegaly in the Newcastle region.","volume":"12","author":"Alexander","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R139","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1210\/jc.2003-031584","article-title":"Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.","volume":"89","author":"Ayuk","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R140","first-page":"293","article-title":"An audit of outcome of treatment in acromegaly.","volume":"86","author":"Bates","year":"1993","journal-title":"Q J Med"},{"key":"2020071611542863200_R141","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","article-title":"Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly.","volume":"58","author":"Beauregard","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R142","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly.","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R143","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1987.tb00805.x","article-title":"Acromegaly.","volume":"26","author":"Nabarro","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R144","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.","volume":"83","author":"Orme","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","article-title":"Determinants of clinical outcome and survival in acromegaly.","volume":"41","author":"Rajasoorya","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R146","first-page":"1","article-title":"Mortality in acromegaly.","volume":"39","author":"Wright","year":"1970","journal-title":"Q J Med"},{"key":"2020071611542863200_R147","first-page":"55","article-title":"Long-term survival and cardiovascular complications in patients with acromegaly and pituitary gigantism.","volume":"21","author":"Shimatsu","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2020071611542863200_R148","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R149","first-page":"3419","article-title":"Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.","volume":"83","author":"Swearingen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R150","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1210\/jc.2003-032041","article-title":"Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements.","volume":"89","author":"Biermasz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R151","first-page":"439","article-title":"The pituitary gland","volume":"Butterworth","author":"Evans","year":"1966","journal-title":"In: Harris G, Donovan B, eds. London:"},{"key":"2020071611542863200_R152","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.0954-6820.1988.tb15881.x","article-title":"and 1984.","volume":"223","author":"Bengtsson","year":"1955","journal-title":"Acta Med Scand"},{"key":"2020071611542863200_R153","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03344942","article-title":"Acromegaly: an epidemiological study.","volume":"16","author":"Etxabe","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"2020071611542863200_R154","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jcem.83.10.5111","article-title":"Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.","volume":"83","author":"Abosch","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R155","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1210\/jc.2004-1381","article-title":"A nationwide survey of mortality in acromegaly.","volume":"90","author":"Kauppinen-Ma\u0308kelin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R156","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis.","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R157","first-page":"526","article-title":"Criteria for cure of acromegaly: a consensus statement.","volume":"85","author":"Giustina","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R158","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1210\/jc.2002-011841","article-title":"Guidelines for acromegaly management.","volume":"87","author":"Melmed","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R159","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/eje.1.02036","article-title":"Consensus statement: medical management of acromegaly.","volume":"153","author":"Melmed","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","article-title":"A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.","volume":"159","author":"Holdaway","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R161","first-page":"2646","article-title":"Current treatment guidelines for acromegaly.","volume":"83","author":"Melmed","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R162","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00701-004-0466-2","article-title":"Treatment outcomes and mortality of 94 patients with acromegaly.","volume":"147","author":"Trepp","year":"2005","journal-title":"Acta Neurochir (Wien)"},{"key":"2020071611542863200_R163","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2265.2007.02836.x","article-title":"Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice.","volume":"67","author":"Pokrajac","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R164","first-page":"1312","article-title":"Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women.","volume":"78","author":"Chapman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/000456328902600226","article-title":"Normal growth hormone response to the 75 g oral glucose tolerance test measured by immunoradiometric assay.","volume":"26","author":"Stewart","year":"1989","journal-title":"Ann Clin Biochem"},{"key":"2020071611542863200_R166","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1210\/jcem-70-3-771","article-title":"Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.","volume":"70","author":"Hattori","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R167","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1015314906972","article-title":"Gender and age in the biochemical assessment of cure of acromegaly.","volume":"4","author":"Freda","year":"2001","journal-title":"Pituitary"},{"key":"2020071611542863200_R168","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1210\/jcem.87.7.8631","article-title":"Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?","volume":"87","author":"Costa","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R169","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/ghir.2000.0171","article-title":"Does the GH-IGF axis play a role in cancer pathogenesis?","volume":"10","author":"Cohen","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"2020071611542863200_R170","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0","article-title":"Acromegaly and gastrointestinal cancer.","volume":"68","author":"Ron","year":"1991","journal-title":"Cancer"},{"key":"2020071611542863200_R171","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1210\/jcem.86.7.7635","article-title":"Acromegaly and cancer: not a problem?","volume":"86","author":"Melmed","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R172","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.beem.2008.08.011","article-title":"Acromegaly, growth hormone and cancer risk.","volume":"22","author":"Renehan","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020071611542863200_R173","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","article-title":"Acromegaly: re-thinking the cancer risk.","volume":"9","author":"Loeper","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"2020071611542863200_R174","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2265.2001.01418.x","article-title":"Colorectal neoplasia in acromegaly.","volume":"55","author":"Jenkins","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R175","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/gut.52.9.1387","article-title":"Colorectal screening guidelines in acromegaly.","volume":"52","author":"Perry","year":"2003","journal-title":"Gut"},{"key":"2020071611542863200_R176","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2265.2001.01355.x","article-title":"Screening colonoscopy for acromegaly in perspective.","volume":"55","author":"Renehan","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R177","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-2004-814150","article-title":"Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications.","volume":"35","author":"Renehan","year":"2003","journal-title":"Horm Metab Res"},{"key":"2020071611542863200_R178","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2265.1997.00253.x","article-title":"Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly.","volume":"47","author":"Colao","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R179","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.1997.v112.agast970594","article-title":"Colorectal cancer screening: clinical guidelines and rationale.","volume":"112","author":"Winawer","year":"1997","journal-title":"Gastroenterology"},{"key":"2020071611542863200_R180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2005.02316.x","article-title":"High prevalence of differentiated thyroid carcinoma in acromegaly.","volume":"63","author":"Tita","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R181","first-page":"193","article-title":"Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.","volume":"85","author":"Colao","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R182","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1020798430884","article-title":"Pathogenesis and prevalence of hypertension in acromegaly.","volume":"4","author":"Bondanelli","year":"2001","journal-title":"Pituitary"},{"key":"2020071611542863200_R183","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF03349164","article-title":"Diagnosis and treatment of acromegaly complications.","volume":"26","author":"Giustina","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"2020071611542863200_R184","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1096-6374(03)00030-3","article-title":"Long-term treatment outcome in acromegaly.","volume":"13","author":"Holdaway","year":"2003","journal-title":"Growth Horm IGF Res"},{"key":"2020071611542863200_R185","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1550-8528.1994.tb00097.x","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932.","volume":"2","author":"Cushing","year":"1994","journal-title":"Obes Res"},{"key":"2020071611542863200_R186","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","article-title":"The natural history of Cushing\u2019s syndrome.","volume":"13","author":"Plotz","year":"1952","journal-title":"Am J Med"},{"key":"2020071611542863200_R187","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(82)92749-0","article-title":"Cushing\u2019s syndrome\u2013killing disease: discriminatory value of signs and symptoms aiding early diagnosis.","volume":"2","author":"Ross","year":"1982","journal-title":"Lancet"},{"key":"2020071611542863200_R188","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach.","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R189","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.1990.tb03890.x","article-title":"Transsphenoidal surgery for Cushing\u2019s disease: does what is removed determine the endocrine outcome?","volume":"33","author":"Burke","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R190","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing\u2019s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.","volume":"92","author":"Dekkers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R191","first-page":"461","article-title":"Long-term results of treatment of Cushing\u2019s disease by adrenalectomy.","volume":"157","author":"Grabner","year":"1991","journal-title":"Eur J Surg"},{"key":"2020071611542863200_R192","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1210\/jcem-66-5-1056","article-title":"Transsphenoidal pituitary surgery for the treatment of Cushing\u2019s disease: results in 64 patients and long term follow-up studies.","volume":"66","author":"Guilhaume","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R193","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing\u2019s disease: initial outcome and long-term results.","volume":"89","author":"Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R194","first-page":"117","article-title":"Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study.","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R195","first-page":"1088","article-title":"Long-term outcome of bilateral adrenalectomy in patients with Cushing\u2019s syndrome.","volume":"116","author":"O'Riordain","year":"1994","journal-title":"Surgery"},{"key":"2020071611542863200_R196","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","article-title":"The survival and well-being of patients treated for Cushing\u2019s syndrome.","volume":"245","author":"Pikkarainen","year":"1999","journal-title":"J Intern Med"},{"key":"2020071611542863200_R197","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","article-title":"Long-term mortality after transsphenoidal surgery for Cushing disease.","volume":"130","author":"Swearingen","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020071611542863200_R198","first-page":"16","article-title":"Survival and causes of death after adrenalectomy for Cushing\u2019s disease.","volume":"97","author":"Welbourn","year":"1985","journal-title":"Surgery"},{"key":"2020071611542863200_R199","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure.","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R200","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome.","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"2020071611542863200_R201","first-page":"3617","article-title":"11 \u03b2-Hydroxysteroid dehydrogenase activity in Cushing\u2019s syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.","volume":"80","author":"Stewart","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/01.HYP.12.1.11","article-title":"Altered circadian blood pressure rhythm in patients with Cushing\u2019s syndrome.","volume":"12","author":"Imai","year":"1988","journal-title":"Hypertension"},{"key":"2020071611542863200_R203","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.beem.2006.07.006","article-title":"Hypertension in Cushing\u2019s syndrome.","volume":"20","author":"Magiakou","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2020071611542863200_R204","first-page":"713","article-title":"Insulin resistance and cardiovascular disease.","volume":"86","author":"McFarlane","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R205","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/sleep\/15.6.514","article-title":"Sleep architecture and sleep apnea in patients with Cushing\u2019s disease.","volume":"15","author":"Shipley","year":"1992","journal-title":"Sleep"},{"key":"2020071611542863200_R206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem-62-2-275","article-title":"Multiple factors contribute to the pathogenesis of hypertension in Cushing\u2019s syndrome.","volume":"62","author":"Saruta","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R207","first-page":"1734","article-title":"Blood pressure in children and adolescents with Cushing\u2019s syndrome before and after surgical care.","volume":"82","author":"Magiakou","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R208","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement.","volume":"93","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R209","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0735-1097(03)00493-5","article-title":"Left ventricular structural and functional characteristics in Cushing\u2019s syndrome.","volume":"41","author":"Muiesan","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2020071611542863200_R210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1540-8175.2007.00572.x","article-title":"Assessment of left ventricular diastolic function and Tei index by tissue Doppler imaging in patients with Cushing\u2019s syndrome.","volume":"25","author":"Baykan","year":"2008","journal-title":"Echocardiography"},{"key":"2020071611542863200_R211","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing\u2019s disease during active disease and 1 year after disease remission.","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R212","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing\u2019s syndrome: a systematic review.","volume":"94","author":"Van Zaane","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R213","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11102-005-1172-7","article-title":"Cardiovascular risk in Cushing\u2019s syndrome.","volume":"7","author":"Arnaldi","year":"2004","journal-title":"Pituitary"},{"key":"2020071611542863200_R214","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1490543","article-title":"Hepatic steatosis in Cushing\u2019s syndrome: a radiological assessment using computed tomography.","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R215","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/pgmj.62.729.657","article-title":"Cushing\u2019s syndrome\u2014transitory immune deficiency state?","volume":"62","author":"Wu\u0308rzburger","year":"1986","journal-title":"Postgrad Med J"},{"key":"2020071611542863200_R216","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1055\/s-2000-5810","article-title":"Pneumocystis carinii pneumonia associated with a rapid reduction of cortisol level in a patient with ectopic ACTH syndrome treated by octreotide and ketoconazole.","volume":"108","author":"Kim","year":"2000","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020071611542863200_R217","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/s-2008-1062729","article-title":"Fatal Pneumocystis jirovecii pneumonia in a case of ectopic Cushing\u2019s syndrome due to neuroendocrine carcinoma of the kidney.","volume":"116","author":"Arlt","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020071611542863200_R218","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MAJ.0b013e3180a5e924","article-title":"\u201cRescue\u201d bilateral adrenalectomy in paraneoplastic Cushing\u2019s syndrome with invasive Aspergillus fumigatus infection.","volume":"334","author":"Joubert","year":"2007","journal-title":"Am J Med Sci"},{"key":"2020071611542863200_R219","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections.","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"2020071611542863200_R220","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0954-6111(98)90320-1","article-title":"Cushing\u2019s disease and tuberculosis.","volume":"92","author":"Hill","year":"1998","journal-title":"Respir Med"},{"key":"2020071611542863200_R221","first-page":"1137","article-title":"Cytomegalovirus infection in a patient with endogenous Cushing\u2019s syndrome.","volume":"26","author":"Dutta","year":"2005","journal-title":"Saudi Med J"},{"key":"2020071611542863200_R222","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(00)02142-5","article-title":"Cryptococcal meningitis, an endocrine emergency?","volume":"355","author":"Razavi","year":"2000","journal-title":"Lancet"},{"key":"2020071611542863200_R223","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF03347735","article-title":"Disseminated nocardiosis in a patient with Cushing\u2019s syndrome.","volume":"17","author":"Boscaro","year":"1994","journal-title":"J Endocrinol Invest"},{"key":"2020071611542863200_R224","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation.","volume":"332","author":"Chrousos","year":"1995","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R225","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline.","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R226","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/er.2006-0002","article-title":"Craniopharyngiomas.","volume":"27","author":"Karavitaki","year":"2006","journal-title":"Endocr Rev"},{"key":"2020071611542863200_R227","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11102-006-0413-8","article-title":"Craniopharyngioma.","volume":"9","author":"Jane Jr","year":"2006","journal-title":"Pituitary"},{"key":"2020071611542863200_R228","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3171\/foc.1997.3.6.4","article-title":"The descriptive epidemiology of craniopharyngioma","volume":"3","author":"Bunin","year":"1997","journal-title":"Neurosurg Focus"},{"key":"2020071611542863200_R229","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-008-9740-0","article-title":"Clinical epidemiology for childhood primary central nervous system tumors.","volume":"92","author":"Bauchet","year":"2009","journal-title":"J Neurooncol"},{"key":"2020071611542863200_R230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1440-1789.2008.00986.x","article-title":"Malignant craniopharyngioma; case report and review of the literature.","volume":"29","author":"Boongird","year":"2009","journal-title":"Neuropathology"},{"key":"2020071611542863200_R231","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00381-005-1188-3","article-title":"Radiation therapy in the management of pediatric craniopharyngiomas\u2014a review.","volume":"21","author":"Kalapurakal","year":"2005","journal-title":"Childs Nerv Syst"},{"key":"2020071611542863200_R232","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0360-3016(03)01570-0","article-title":"Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults.","volume":"58","author":"Stripp","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R233","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0360-3016(02)02799-2","article-title":"Craniopharyngioma: the St. Jude Children\u2019s Research Hospital experience 1984\u20132001.","volume":"53","author":"Merchant","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R234","first-page":"3897","article-title":"Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence.","volume":"83","author":"Bu\u0308low","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R235","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2265.2004.02196.x","article-title":"High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma.","volume":"62","author":"Pereira","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R236","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s003810050272","article-title":"Outcomes and failure patterns in childhood craniopharyngiomas.","volume":"14","author":"Fisher","year":"1998","journal-title":"Childs Nerv Syst"},{"key":"2020071611542863200_R237","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0360-3016(99)00030-9","article-title":"The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature.","volume":"44","author":"Habrand","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R238","first-page":"193","article-title":"Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up.","volume":"69","author":"Muller","year":"2008","journal-title":"Horm Res"},{"key":"2020071611542863200_R239","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0167-8140(93)90039-B","article-title":"Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation.","volume":"27","author":"Regine","year":"1993","journal-title":"Radiother Oncol"},{"key":"2020071611542863200_R240","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/1097-0142(19810301)47:5<847::AID-CNCR2820470505>3.0.CO;2-W","article-title":"Treatment results of craniopharyngiomas.","volume":"47","author":"Sung","year":"1981","journal-title":"Cancer"},{"key":"2020071611542863200_R241","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00381-005-1202-9","article-title":"Craniopharyngiomas in children: surgical experience at Children\u2019s Memorial Hospital.","volume":"21","author":"Tomita","year":"2005","journal-title":"Childs Nerv Syst"},{"key":"2020071611542863200_R242","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3171\/jns.1996.85.1.0073","article-title":"Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?","volume":"85","author":"De Vile","year":"1996","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R243","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0360-3016(93)90227-M","article-title":"20-Year experience in childhood craniopharyngioma.","volume":"27","author":"Hetelekidis","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R244","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mpo.10247","article-title":"Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.","volume":"40","author":"Kalapurakal","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"2020071611542863200_R245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0360-3016(98)00257-0","article-title":"Craniopharyngioma in children.","volume":"42","author":"Khafaga","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R246","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3171\/PED\/2008\/1\/2\/126","article-title":"Long-term outcome in children treated for craniopharyngioma with and without radiotherapy.","volume":"1","author":"Lin","year":"2008","journal-title":"J Neurosurg Pediatr"},{"key":"2020071611542863200_R247","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1469-8749.2004.tb00476.x","article-title":"Outcome of a craniopharyngioma in children: long-term complications and quality of life.","volume":"46","author":"Poretti","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"2020071611542863200_R248","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000120866","article-title":"Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma. A 20-year experience.","volume":"21","author":"Scott","year":"1994","journal-title":"Pediatr Neurosurg"},{"key":"2020071611542863200_R249","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0360-3016(92)90705-M","article-title":"Pediatric craniopharyngiomas\u2014 long-term results of combined treatment with surgery and radiation.","volume":"24","author":"Regine","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","article-title":"Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.","volume":"62","author":"Karavitaki","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R251","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/jns.2002.97.1.0003","article-title":"Craniopharyngioma in adults and children: a study of 122 surgical cases.","volume":"97","author":"Van Effenterre","year":"2002","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R252","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jnnp.34.1.37","article-title":"Craniopharyngiomas\u2014a summary of 85 cases.","volume":"34","author":"Bartlett","year":"1971","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020071611542863200_R253","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3171\/jns.1999.90.2.0237","article-title":"Surgical treatment of craniopharyngiomas: experience with 168 patients.","volume":"90","author":"Fahlbusch","year":"1999","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R254","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2005.04.015","article-title":"Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma.","volume":"77","author":"Pemberton","year":"2005","journal-title":"Radiother Oncol"},{"key":"2020071611542863200_R255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-8140(93)90019-5","article-title":"Craniopharyngioma\u2014long-term results following limited surgery and radiotherapy.","volume":"26","author":"Rajan","year":"1993","journal-title":"Radiother Oncol"},{"key":"2020071611542863200_R256","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/jns.1990.73.1.0003","article-title":"Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients.","volume":"73","author":"Ya\u00b0argil","year":"1990","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R257","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/1097-0142(197604)37:4<1944::AID-CNCR2820370446>3.0.CO;2-#","article-title":"Craniopharyngiomas: a clinical and pathological review.","volume":"37","author":"Petito","year":"1976","journal-title":"Cancer"},{"key":"2020071611542863200_R258","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000120869","article-title":"The role of radiation-therapy in the treatment of craniopharyngioma.","volume":"21","author":"Wara","year":"1994","journal-title":"Pediatr Neurosurg"},{"key":"2020071611542863200_R259","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00381-005-1186-5","article-title":"Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.","volume":"21","author":"Caldarelli","year":"2005","journal-title":"Childs Nerv Syst"},{"key":"2020071611542863200_R260","first-page":"3","article-title":"Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.","volume":"106","author":"Puget","year":"2007","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R261","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00381-005-1201-x","article-title":"Radical resection of craniopharyngioma.","volume":"21","author":"Zuccaro","year":"2005","journal-title":"Childs Nerv Syst"},{"key":"2020071611542863200_R262","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3171\/JNS\/2008\/109\/7\/0006","article-title":"Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series.","volume":"109","author":"Gardner","year":"2008","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R263","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.1995.tb02664.x","article-title":"Hypothalamic-pituitary dysfunction in patients with craniopharyngioma.","volume":"42","author":"Paja","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R264","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3171\/jns.2005.102.4.0650","article-title":"Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma.","volume":"102","author":"Chakrabarti","year":"2005","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3171\/jns.1992.76.1.0047","article-title":"Aggressive surgical management of craniopharyngiomas in children.","volume":"76","author":"Hoffman","year":"1992","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R266","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000120856","article-title":"Craniopharyngioma\u2014endocrine abnormalities at presentation.","volume":"21","author":"Sklar","year":"1994","journal-title":"Pediatr Neurosurg"},{"key":"2020071611542863200_R267","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/adc.75.2.108","article-title":"Growth and endocrine sequelae of craniopharyngioma.","volume":"75","author":"DeVile","year":"1996","journal-title":"Arch Dis Child"},{"key":"2020071611542863200_R268","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/adc.57.11.837","article-title":"Endocrine function, morbidity, and mortality after surgery for craniopharyngioma.","volume":"57","author":"Lyen","year":"1982","journal-title":"Arch Dis Child"},{"key":"2020071611542863200_R269","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3171\/jns.1999.90.2.0251","article-title":"Surgical treatment of craniopharyngiomas: endocrinological results.","volume":"90","author":"Honegger","year":"1999","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R270","first-page":"388","article-title":"Clinical outcome in children with recurrent craniopharyngioma after primary surgery.","volume":"6","author":"Kalapurakal","year":"2000","journal-title":"Cancer J"},{"key":"2020071611542863200_R271","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0360-3016(89)90543-9","article-title":"The role of radiation therapy in the management of childhood craniopharyngioma.","volume":"17","author":"Weiss","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R272","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01401321","article-title":"Evaluation of anterior-pituitary function in adult patients with craniopharyngiomas.","volume":"71","author":"Barreca","year":"1984","journal-title":"Acta Neurochir (Wien)"},{"key":"2020071611542863200_R273","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/jc.2003-030442","article-title":"Features of the metabolic syndrome after childhood craniopharyngioma.","volume":"89","author":"Srinivasan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R274","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00442445","article-title":"Long-term follow-up of children with craniopharyngioma.","volume":"142","author":"Stahnke","year":"1984","journal-title":"Eur J Pediatr"},{"key":"2020071611542863200_R275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000120858","article-title":"The endocrine outcome after surgical removal of craniopharyngiomas.","volume":"21","author":"Curtis","year":"1994","journal-title":"Pediatr Neurosurg"},{"key":"2020071611542863200_R276","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1227\/00006123-198209000-00008","article-title":"Craniopharyngiomas in children.","volume":"11","author":"Carmel","year":"1982","journal-title":"Neurosurgery"},{"key":"2020071611542863200_R277","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3171\/jns.1985.62.5.0648","article-title":"The efficacy of radiotherapy for craniopharyngioma","volume":"62","author":"Manaka","year":"1985","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R278","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/02688699209002926","article-title":"Pediatric craniopharyngiomas\u2014a regional review.","volume":"6","author":"Graham","year":"1992","journal-title":"Br J Neurosurg"},{"key":"2020071611542863200_R279","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3171\/jns.1949.6.6.0503","article-title":"The surgery of the craniopharyngiomas.","volume":"6","author":"Gordy","year":"1949","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R280","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jama.1948.02890270010003","article-title":"Surgical experience with tumors of the pituitary gland.","volume":"136","author":"Grant","year":"1948","journal-title":"J Am Med Assoc"},{"key":"2020071611542863200_R281","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11102-008-0165-8","article-title":"Craniopharyngioma: historical notes.","volume":"12","author":"Lindholm","year":"2009","journal-title":"Pituitary"},{"key":"2020071611542863200_R282","first-page":"123","article-title":"Treatment of recurrent craniopharyngiomas.","volume":"49","author":"Barua","year":"2003","journal-title":"Kobe J Med Sci"},{"key":"2020071611542863200_R283","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0936-6555(05)81101-X","article-title":"Radiotherapy for the treatment of recurrent craniopharyngioma.","volume":"4","author":"Jose","year":"1992","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2020071611542863200_R284","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clineuro.2007.10.013","article-title":"Craniopharyngioma: surgical experience of 309 cases in China.","volume":"110","author":"Shi","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"2020071611542863200_R285","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00381-007-0456-9","article-title":"Craniopharyngiomas in children: recurrence, reoperation and outcome.","volume":"24","author":"Vinchon","year":"2008","journal-title":"Childs Nerv Syst"},{"key":"2020071611542863200_R286","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/pgmj.64.754.617","article-title":"Hematological, neurological and psychiatric complications of chronic hypothermia following surgery for craniopharyngioma.","volume":"64","author":"Griffiths","year":"1988","journal-title":"Postgrad Med J"},{"key":"2020071611542863200_R287","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe.","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R288","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2004-832339","article-title":"Prognosis and sequela in patients with childhood craniopharyngioma. Results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000.","volume":"216","author":"Mu\u0308ller","year":"2004","journal-title":"Klinische Padiatrie"},{"key":"2020071611542863200_R289","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1651-2227.1988.tb10705.x","article-title":"Children with craniopharyngioma\u2014early growth failure and rapid postoperative weight-gain.","volume":"77","author":"Sorva","year":"1988","journal-title":"Acta Paediatrica Scandinavica"},{"key":"2020071611542863200_R290","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00006123-200002000-00007","article-title":"Long-term outcomes for surgically resected craniopharyngiomas.","volume":"46","author":"Duff","year":"2000","journal-title":"Neurosurgery"},{"key":"2020071611542863200_R291","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.amjmed.2004.06.035","article-title":"Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage.","volume":"118","author":"Daousi","year":"2005","journal-title":"Am J Med"},{"key":"2020071611542863200_R292","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1210\/jc.2003-031751","article-title":"Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.","volume":"89","author":"Mu\u0308ller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R293","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2001-16855","article-title":"Obesity after childhood craniopharyngioma\u2014German multicenter study on pre-operative risk factors and quality of life.","volume":"213","author":"Mu\u0308ller","year":"2001","journal-title":"Klinische Padiatrie"},{"key":"2020071611542863200_R294","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2003-45499","article-title":"Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma.","volume":"215","author":"Mu\u0308ller","year":"2003","journal-title":"Klinische Padiatrie"},{"key":"2020071611542863200_R295","first-page":"2734","article-title":"Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.","volume":"81","author":"Vile","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R296","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jc.2002-021180","article-title":"Risk factors for the development of obesity in children surviving brain tumors.","volume":"88","author":"Lustig","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R297","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-2003-42722","article-title":"Perioperative dexamethasone treatment in childhood craniopharyngioma. Influence on short-term and long-term weight gain.","volume":"111","author":"Mu\u0308ller","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2020071611542863200_R298","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1380089","article-title":"Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite.","volume":"138","author":"Roth","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R299","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1210\/jc.2002-021797","article-title":"Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity.","volume":"88","author":"Harz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R300","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1203\/pdr.0b013e3180332cd6","article-title":"Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma.","volume":"61","author":"Roth","year":"2007","journal-title":"Pediatr Res"},{"key":"2020071611542863200_R301","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jcem.87.8.8751","article-title":"Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients.","volume":"87","author":"Mu\u0308ller","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R302","first-page":"220","article-title":"Hypothalamic obesity: causes, consequences, treatment.","volume":"6","author":"Lustig","year":"2008","journal-title":"Pediatr Endocrinol Rev"},{"key":"2020071611542863200_R303","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome.","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"key":"2020071611542863200_R304","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pediatrneurol.2007.11.007","article-title":"Cardiac risk after craniopharyngioma therapy.","volume":"38","author":"Mong","year":"2008","journal-title":"Pediatr Neurol"},{"key":"2020071611542863200_R305","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01401137","article-title":"Pathological characteristics of surgically removed craniopharyngiomas. Analysis of 131 cases.","volume":"124","author":"Szeifert","year":"1993","journal-title":"Acta Neurochirurgica"},{"key":"2020071611542863200_R306","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3171\/jns.1990.73.1.0012","article-title":"Correlation of clinical and pathological features in surgically treated craniopharyngiomas.","volume":"73","author":"Adamson","year":"1990","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R307","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3171\/jns.1995.83.2.0206","article-title":"Papillary craniopharyngioma\u2014a clinicopathological study of 48 cases.","volume":"83","author":"Crotty","year":"1995","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R308","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1227\/00006123-199412000-00001","article-title":"Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.","volume":"35","author":"Weiner","year":"1994","journal-title":"Neurosurgery"},{"key":"2020071611542863200_R309","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","article-title":"The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.","volume":"38","author":"Brada","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R310","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3171\/jns.1998.89.6.0933","article-title":"Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control.","volume":"89","author":"Breen","year":"1998","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R311","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/eje.1.02298","article-title":"Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors.","volume":"155","author":"Ferrante","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2020071611542863200_R312","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2265.1998.00393.x","article-title":"Radiotherapy for non-function pituitary tumours","volume":"48","author":"Gittoes","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R313","first-page":"398","article-title":"Influence of radiotherapy on long-term relapse in clinically non-secreting pituitary adenomas. A retrospective study (1970\u20131988).","volume":"2","author":"Jaffrain-Rea","year":"1993","journal-title":"Eur J Med"},{"key":"2020071611542863200_R314","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1227\/01.NEU.0000126885.71242.D7","article-title":"The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas.","volume":"55","author":"Park","year":"2004","journal-title":"Neurosurgery"},{"key":"2020071611542863200_R315","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(92)90941-A","article-title":"Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors.","volume":"30","author":"Tsang","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R316","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijrobp.2006.09.049","article-title":"Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy.","volume":"67","author":"Bergh","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R317","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2000.01153.x","article-title":"Non-functioning pituitary adenomas: indications for postoperative radiotherapy.","volume":"53","author":"Woollons","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R318","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jcem.85.10.6870","article-title":"Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.","volume":"85","author":"Barrande","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R319","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.2000.01095.x","article-title":"Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels.","volume":"53","author":"Biermasz","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R320","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1210\/jcem.85.7.6699","article-title":"Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.","volume":"85","author":"Biermasz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R321","first-page":"2068","article-title":"Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure.","volume":"85","author":"Powell","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R322","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1590\/S0004-27302007000800024","article-title":"Radiotherapy and radiosurgery for Cushing\u2019s disease.","volume":"51","author":"Minniti","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"2020071611542863200_R323","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","article-title":"The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing\u2019s disease.","volume":"336","author":"Estrada","year":"1997","journal-title":"N Engl J Med"},{"key":"2020071611542863200_R324","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11060-007-9344-0","article-title":"Long-term follow-up results of postoperative radiation therapy for Cushing\u2019s disease.","volume":"84","author":"Minniti","year":"2007","journal-title":"J Neurooncol"},{"key":"2020071611542863200_R325","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/jc.2005-1616","article-title":"Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.","volume":"91","author":"Jenkins","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R326","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3","article-title":"Incidence of cerebral infarction after radiotherapy for pituitary adenoma.","volume":"63","author":"Flickinger","year":"1989","journal-title":"Cancer"},{"key":"2020071611542863200_R327","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0360-3016(99)00159-5","article-title":"The incidence of cerebrovascular accidents in patients with pituitary adenoma.","volume":"45","author":"Brada","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020071611542863200_R328","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2002.01570.x","article-title":"Cerebrovascular mortality in patients with pituitary adenoma.","volume":"57","author":"Brada","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R329","first-page":"145","article-title":"Hypopituitarism following external radiotherapy for pituitary tumours in adults.","volume":"70","author":"Littley","year":"1989","journal-title":"Q J Med"},{"key":"2020071611542863200_R330","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3171\/jns.1990.73.4.0502","article-title":"The long-term side effects of radiation therapy for benign brain tumors in adults.","volume":"73","author":"al-Mefty","year":"1990","journal-title":"J Neurosurg"},{"key":"2020071611542863200_R331","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1210\/jc.2002-020526","article-title":"Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors.","volume":"87","author":"Erfurth","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071611542863200_R332","first-page":"108","article-title":"Is the pathology of radiation injury different in small vs large blood vessels?","volume":"1","author":"Fajardo","year":"1999","journal-title":"Cardiovasc Radiat Med"},{"key":"2020071611542863200_R333","first-page":"297","article-title":"Vascular lesions following radiation.","volume":"23","author":"Fajardo","year":"1988","journal-title":"Pathol Annu"},{"key":"2020071611542863200_R334","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000416574","article-title":"The unique physiology of endothelial cells and its implications in radiobiology.","volume":"23","author":"Fajardo","year":"1989","journal-title":"Front Radiat Ther Oncol"},{"key":"2020071611542863200_R335","first-page":"244","article-title":"Pathogenesis of radiation-induced myocardial fibrosis.","volume":"29","author":"Fajardo","year":"1973","journal-title":"Lab Invest"},{"key":"2020071611542863200_R336","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/cncr.2820690528","article-title":"Coronary artery disease mortality in patients treated for Hodgkin\u2019s disease.","volume":"69","author":"Boivin","year":"1992","journal-title":"Cancer"},{"key":"2020071611542863200_R337","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease.","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"2020071611542863200_R338","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/B:PITU.0000004801.95086.e2","article-title":"Radiotherapy for non-functioning pituitary tumors\u2014when and under what circumstances?","volume":"6","author":"Gittoes","year":"2003","journal-title":"Pituitary"},{"key":"2020071611542863200_R339","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0936-6555(05)80187-6","article-title":"Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962\u20131990.","volume":"6","author":"Bliss","year":"1994","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2020071611542863200_R340","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.304.6838.1343","article-title":"Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.","volume":"304","author":"Brada","year":"1992","journal-title":"BMJ"},{"key":"2020071611542863200_R341","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/1097-0142(19931001)72:7<2227::AID-CNCR2820720727>3.0.CO;2-I","article-title":"Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk.","volume":"72","author":"Tsang","year":"1993","journal-title":"Cancer"},{"key":"2020071611542863200_R342","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","article-title":"Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group.","volume":"49","author":"Popovic","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071611542863200_R343","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11154-007-9065-x","article-title":"Radiation therapy in acromegaly.","volume":"9","author":"Shih","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"2020071611542863200_R344","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1507\/endocrj.50.163","article-title":"Mortality in 154 surgically treated patients with acromegaly\u2014a 10-year follow-up survey.","volume":"50","author":"Arita","year":"2003","journal-title":"Endocr J"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/31\/3\/301\/10335111\/edrv0301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/31\/3\/301\/10335111\/edrv0301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T09:25:37Z","timestamp":1711531537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/31\/3\/301\/2354746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":344,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2009-0033","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}